Andrea Charles | 03/17/2011
With more clinical research being conducted India, there is growing pressure to address pharmacovigilance concerns. Dr. Seema Rajsingh, Head- Pharmacovigilance at Biocon, joins Andrea Charles from Pharma IQ, to discuss the main challenges the industry currently faces, setting the standards for proactive pharmacovigilance in India and the strategies Indian pharmaceutical companies are employing to optimise their drug safety teams and pharmacovigilance activities.
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2025
September 1 - 3 2025
Palace Hotel Berlin, Germany
Register Now |
View Agenda |
Learn More
GenAI Life Science & Health 2025
September 1 - 3 2025
Berlin, Germany
Register Now |
View Agenda |
Learn More